Nature-based virtual reality program for depression in Alzheimer's patients
Official title: Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease: a Pilot Randomized Controlled Trial
Run by Centre for Addiction and Mental Health · NCT06732128 · Data updated 2026-11-12
This study is testing if a nature-based virtual reality program can help reduce depression in people with Alzheimer's disease by providing enjoyable sessions at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | January 6, 2025 |
| Main results expected | June 11, 2025 |
| Study ends | November 11, 2025 |
| Registry record updated | December 13, 2024 |
| Trial ID | NCT06732128 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50 and older with a clinical diagnosis of mild to early-moderate Alzheimer's disease and experiencing mild depressive symptoms.
✕Probably not a fit
Patients with unstable medical or psychiatric conditions, significant visual or hearing impairments, or severe depressive symptoms may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention involves a 4-week program utilizing nature-based virtual reality (VR) sessions delivered in-home to address behavioral and psychological symptoms of dementia (BPSD), particularly depression, in individuals with Alzheimer's disease. Participants will engage in 15-minute VR sessions twice a week, with the option for caregivers to provide feedback on the intervention. The study aims to assess the feasibility and effectiveness of VR as a non-pharmacological treatment for depression in older adults with dementia, addressing barriers such as accessibility and adherence to traditional therapies.
Why it matters
Potential benefit: If successful, this program could enhance the quality of life for Alzheimer's patients by reducing depressive symptoms and prolonging their ability to live independently.
How similar studies have gone: While previous literature on VR interventions for older adults is limited, the approach is innovative and has not been extensively tested in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of mild to early-moderate stage AD (including mixed dementia with AD) using the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. Criteria * Age of 50 years or older * Medical stability to participate in the trial * Patient Health Questionnaire score 5-14 * Investigator judgement on whether the participant is comfortable with technology * Access to WiFi and a smart device for connecting on WebEx and downloading the Fitbit and Muse applications * Have someone available to be present during all sessions Exclusion Criteria: * Unstable medical or psychiatric condition, including substance use based on an investigator opinion * Visual or hearing impairments that would impair participation * Patient Health Questionnaire score 15-27 and/or score of 1 or 2 in section E question 1 of the Cornell Scale for Depression in Dementia * Any other reason, which will make the study participation intolerable for the participant in the opinion of the study investigator
Where it's running
-
Centre for Addictions and Mental Health (CAMH)
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: HARMEHR SEKHON, PhD — CAMH and McGill/St. Mary's Research Centre
- Study coordinator: Ashnie Sukhu, BSc
- Email: ashnie.sukhu@camh.ca
- Phone: (416) 535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A study on brain health and aging in Bordeaux.
This study is trying to understand how different factors, like diet and health, affect brain aging and the risk of dementia in people aged 55 and older living in Bordeaux.
-
Using psilocybin to treat depression in people with mild cognitive impairment or early Alzheimer's disease
This study is testing if psilocybin can help improve mood and quality of life for people with mild cognitive impairment or early Alzheimer's disease who are feeling depressed.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.